Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Public ClinicalTrials.gov record NCT03070951. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicentre, Randomized, Double-blind, Placebo-controlled Study Investigating the Efficacy and Safety of Daily Oral Administration of OBE2109 Alone and in Combination With Add-back Therapy for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
Study identification
- NCT ID
- NCT03070951
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- ObsEva SA
- Industry
- Enrollment
- 511 participants
Conditions and interventions
Conditions
Interventions
- OBE2109 Drug
- Placebo to match OBE2109 Drug
- Placebo to match Add-back Drug
- Add-back Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 22, 2017
- Primary completion
- Sep 15, 2019
- Completion
- Oct 3, 2020
- Last update posted
- Mar 4, 2021
2017 – 2020
United States locations
- U.S. sites
- 23
- U.S. states
- 17
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site reference ID 905 | Chino | California | 91710 | — |
| Site reference ID 918 | Huntington Park | California | 29572 | — |
| Site reference ID 902 | San Diego | California | 92123 | — |
| Site reference ID 903 | Denver | Colorado | 80209 | — |
| Site reference ID 913 | Bradenton | Florida | 34209 | — |
| Site reference ID 912 | Orlando | Florida | 32806 | — |
| Site reference ID 915 | Augusta | Georgia | 30912 | — |
| Site reference ID 924 | Nampa | Idaho | 83687 | — |
| Site reference ID 926 | Covington | Louisiana | 70433 | — |
| Site reference ID 927 | Metairie | Louisiana | 70006 | — |
| Site reference ID 900 | Metairie | Louisiana | 92123 | — |
| Site reference ID 901 | Canton | Michigan | 48187 | — |
| Site reference ID 932 | Detroit | Michigan | 48201 | — |
| Site reference ID 916 | Jefferson City | Missouri | 65109 | — |
| Site reference ID 930 | Albuquerque | New Mexico | 87102 | — |
| Site reference ID 933 | West Seneca | New York | 14224 | — |
| Site reference ID 931 | Hamlet | North Carolina | 28345 | — |
| Site reference ID 914 | Westerville | Ohio | 43081 | — |
| Site reference ID 928 | Erie | Pennsylvania | 16507 | — |
| Site reference ID 919 | West Columbia | South Carolina | 37203 | — |
| Site reference ID 907 | Houston | Texas | 77058 | — |
| Site reference ID 911 | Salt Lake City | Utah | 84124 | — |
| Site reference ID 917 | Madison | Wisconsin | 53717 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 73 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03070951, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 4, 2021 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03070951 live on ClinicalTrials.gov.